Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.20
-1.8%		$2.40
$1.72
▼
$73.50
$2.24M0.418,587 shs9,969 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$16.20
-9.3%		$15.53
$5.26
▼
$86.00
$53.48M0.5931,186 shs8,507 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$85.93
-2.8%		$80.89
$32.21
▼
$170.87
$2.64B1.99668,976 shs437,025 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%+0.45%-5.88%-24.58%-96.45%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.00%+0.99%+22.16%+22.96%-47.47%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.00%-12.56%+2.40%+27.89%-24.58%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.20
-1.8%		$2.40
$1.72
▼
$73.50
$2.24M0.418,587 shs9,969 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$16.20
-9.3%		$15.53
$5.26
▼
$86.00
$53.48M0.5931,186 shs8,507 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$85.93
-2.8%		$80.89
$32.21
▼
$170.87
$2.64B1.99668,976 shs437,025 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%+0.45%-5.88%-24.58%-96.45%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.00%+0.99%+22.16%+22.96%-47.47%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.00%-12.56%+2.40%+27.89%-24.58%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
1.00
SellN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
2.00
Hold$55.00239.51% Upside
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.89
Moderate Buy$89.574.24% Upside

Current Analyst Ratings Breakdown

Latest ATPC, EUDA, and WGS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/19/2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/5/2026
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/4/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D)
8/4/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$75.00 ➝ $90.00
8/4/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$90.00
7/28/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
7/15/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
6/29/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$70.00 ➝ $74.00
6/29/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
(Data available from 9/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.52M1.45N/AN/A$22.41 per share0.10
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$6.82M7.10N/AN/A($2.26) per share-7.17
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$427.54M5.99$2.23 per share38.57$10.54 per share8.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.28M-$0.74N/AN/AN/A-85.94%-5.47%-4.94%N/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$2.77MN/AN/AN/AN/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$21.02M-$3.64N/A74.72N/A-23.41%4.12%2.26%10/27/2026 (Estimated)

Latest ATPC, EUDA, and WGS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A$0.15N/A$0.15N/A$0.01 million
8/3/2026Q2 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$0.1879$0.01+$0.1979-$0.60$111.01 million$114.44 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
8.45
8.44
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.18
0.18
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.40
3.30
3.06

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
2.04%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
25.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
181.00 million981,000Not Optionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
22.99 millionN/ANot Optionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,30029.82 million22.32 millionOptionable

Recent News About These Companies

GeneDx Stock Is Down 30% In Last 1 Year, Can It Climb Again in 2027?
September 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/genedx-stock-down-30-last-133314557.html
GeneDx (NASDAQ:WGS) Stock Price Up 7.9% - Here's Why
September 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-genedx-nasdaq-wgs-stock-price-up-79-heres-why-2026-09-24/
GeneDx (NASDAQ:WGS) Trading Down 6.5% - Time to Sell?
September 24, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31044459
GeneDx (NASDAQ:WGS) Stock Price Down 6.5% - Here's Why
September 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-genedx-nasdaq-wgs-stock-price-down-65-heres-why-2026-09-22/
Corient Private Wealth LP Makes New $3.07 Million Investment in GeneDx Holdings Corp. $WGS
September 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-corient-private-wealth-lp-makes-new-307-million-investment-in-genedx-holdings-corp-wgs-2026-09-21/
GeneDx (NASDAQ:WGS) CFO Sells $363,890.08 in Stock
September 19, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-wgs-insider-buying-and-selling-2026-09-19/
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells $363,890.08 in Stock
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-genedx-nasdaq-wgs-cfo-sells-36389008-in-stock-2026-09-18/
GeneDx (NASDAQ:WGS) CEO Sells $1,025,002.61 in Stock
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-genedx-nasdaq-wgs-ceo-sells-102500261-in-stock-2026-09-18/
Financial Contrast: GeneDx (NASDAQ:WGS) versus Hinge Health (NYSE:HNGE)
September 18, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31030885
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Rating of "Moderate Buy" from Analysts
September 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-genedx-holdings-corp-nasdaq-wgs-receives-consensus-rating-of-moderate-buy-from-analysts-2026-09-16/
GeneDx (NASDAQ:WGS) Trading Up 4.2% - What's Next?
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-genedx-nasdaq-wgs-trading-up-42-whats-next-2026-09-15/
How Genedx Holdings Corp. (WGS) Affects Rotational Strategy Timing
September 14, 2026  |  news.stocktradersdaily.comN
GeneDx (NASDAQ:WGS) CFO Kevin Feeley Sells 1,285 Shares of Stock
September 12, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-wgs-insider-buying-and-selling-2026-09-12/
Kevin Feeley Sells 1,285 Shares of GeneDx (NASDAQ:WGS) Stock
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-kevin-feeley-sells-1285-shares-of-genedx-nasdaq-wgs-stock-2026-09-11/
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 3,692 Shares of Stock
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-genedx-nasdaq-wgs-ceo-katherine-stueland-sells-3692-shares-of-stock-2026-09-11/
First Light Asset Management LLC Has $53.82 Million Position in GeneDx Holdings Corp. $WGS
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-first-light-asset-management-llc-has-5382-million-position-in-genedx-holdings-corp-wgs-2026-09-10/
3 Promising Genomics Stocks in the Spotlight in 2026
September 8, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2986615/3-promising-genomics-stocks-in-the-spotlight-in-2026?cid=cs-stocknewsapi-ft-genomics_&_synthetic_biology-2986615
Bank of New York Mellon Corp Invests $4.26 Million in GeneDx Holdings Corp. $WGS
September 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-invests-426-million-in-genedx-holdings-corp-wgs-2026-09-06/
GeneDx Holdings Corp (WGS) Shares Surge 3.3% -- What GF Score of 65 Tells Investors
August 26, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9055136/genedx-holdings-corp-wgs-shares-surge-33-what-gf-score-of-65-tells-investors
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
August 24, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genedx-announces-transformative-study-supporting-123000368.html
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's
August 24, 2026  |  markets.ft.comhttps://markets.ft.com/data/announce/detail?dockey=600-202608240830BIZWIRE_USPRX____20260824_BW639564-1

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$2.20 -0.04 (-1.79%)
Closing price 04:00 PM Eastern
Extended Trading
$2.23 +0.03 (+1.36%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$16.20 -1.66 (-9.29%)
Closing price 03:59 PM Eastern
Extended Trading
$16.68 +0.48 (+2.99%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

GeneDx stock logo

GeneDx NASDAQ:WGS

$85.93 -2.47 (-2.79%)
Closing price 04:00 PM Eastern
Extended Trading
$85.95 +0.02 (+0.02%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas